Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique

Summary

In Martinique, about 33 new cases are diagnosed per year, with a high incidence rate of type 2 endometrial carcinoma which has a poor prognosis with few therapeutic options. Although targeted therapies are used in many types of cancer, they are still possible a minority of patients. In current practice, endometrial cancers do not benefit these therapies. Characterization of the molecular mechanisms involved in the genesis of type 2 endometrial carcinoma could help to identify biomarkers predictive of a response to targeted therapies. We propose to identify the genetic profile of type 2 endometrial carcinomas in Martinique.

Key Facts

Interventions

Conditions

Eligibility

Inclusion Criteria:

* Major subject living in Martinique with the following characteristics :

  * Patients with type 2 endometrial cancer, with anatomopathological confirmation
  * Affiliate or beneficiary of french social security.
  * Free, informed with a written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any research required by the research).

Exclusion Criteria:

* Type 1 adenocarcinoma
* Patients not affiliated to french social security
* Refusal to participate.

Outcome Measures

Locations

Linked Diseases